Citations

Clear

38 citation(s) found for "Weber, Michael".

Systematic Review of the Outcomes of Surgical Treatment of Prostate Metastases to the Spine
Molina, Camilo A. , Fourney, Daryl R. , Fisher, Charles G. , Gokaslan, Ziya L. , Schmidt, Meic H. , Rhines, Laurence D. , Fehlings, Michael G. , Laufer, Ilya , Patel, Shreyaskumar , Rampersaud, Y. Raja , Reynolds, Jeremy , Chou, Dean , Mendel, Ehud , Weber, Michael H. , Sciubba, Daniel M. , Reynolds, Jeremy , Clarke, Michelle J. , Bettegowda, Chetan , Fehlings, Michael G , Reynolds, Jeremy

Mayo Clinic

Global Spine Journal | June 1, 2017 | Volume: 7 | Issue: 5 | Pages: 460-468

10.1177/2192568217710911 | PMID 28811991 Get It

Study Design: Systematic review. Objective: Surgical decompression and reconstruction of symptomatic spinal metastases has improved the quality of life in cancer patients. However, most data has been collected on cohorts of patients with mixed tumor histopathology. We systematically reviewed the literature for prognostic factors specific to the surgical treatment of prostate metastases to the spine. Methods: A systemic review of the literature was conducted to answer the following questions: Question 1. Describe the survival and functional outcomes of surgery or vertebral augmentation for prostate metastases to the spine. Question 2. Determine whether overall tumor burden, Gleason score, preoperative functional markers, and hormonal naivety favor operative intervention. Question 3. Establish whether clinical outcomes vary with the evolution of operative techniques. Results: A total of 16 studies met the preset inclusion criteria. All included studies were retrospective series with a level of evidence of IV. Included studies consistently showed a large effect of hormone-naivety on overall survival. Additionally, studies consistently demonstrated an improvement in motor function and the ability to maintain/regain ambulation following surgery resulting in moderate strength of recommendation. All other parameters were of insufficient or low strength. Conclusions: There is a dearth of literature regarding the surgical treatment of prostate metastases to the spine, which represents an opportunity for future research. Based on existing evidence, it appears that the surgical treatment of prostate metastases to the spine has consistently favorable results. While no consistent preoperative indicators favor nonoperative treatment, hormone-naivety and high Karnofsky performance scores have positive effects on survival and clinical outcomes.
A Systematic Review of Clinical Outcomes and Prognostic Factors for Patients Undergoing Surgery for Spinal Metastases Secondary to Breast Cancer
Sciubba, Daniel M. , Yurter, Alp, Ju, Derek G. , Gokaslan, Ziya L. , Fisher, Charles G. , Rhines, Laurence D. , Fehlings, Michael G. , Fourney, Daryl R. , Mendel, Ehud , Laufer, Ilya , Patel, Shreyaskumar , Rampersaud, Y. Raja , Sahgal, Arjun , Reynolds, Jeremy , Chou, Dean , Weber, Michael H. , Reynolds, Jeremy , Goodwin, C. Rory , Bettegowda, Chetan , Clarke, Michelle J. , Fehlings, Michael G , Reynolds, Jeremy

Mayo Clinic

Global Spine Journal | October 21, 2015 | Volume: 6 | Issue: 5 | Pages: 482-496

10.1055/s-0035-1564807 | PMID 27433433 Get It

Study Design Review of the literature. Objective Surgery and cement augmentation procedures are effective palliative treatment of symptomatic spinal metastases. Our objective is to systematically review the literature to describe the survival, prognostic factors, and clinical outcomes of surgery and cement augmentation procedures for breast cancer metastases to the spine. Methods We performed a literature review using PubMed to identify articles that reported outcomes and/or prognostic factors of the breast cancer patient population with spinal metastases treated with any surgical technique since 1990. Results The median postoperative survival for metastatic breast cancer was 21.7 months (8.2 to 36 months), the mean rate of any pain improvement was 92.9% (76 to 100%), the mean rate of neurologic improvement was 63.8% (53 to 100%), the mean rate of neurologic decline was 4.1% (0 to 8%), and the local tumor control rate was 92.6% (89 to 100%). Kyphoplasty studies reported a high rate of pain control in selected patients. Negative prognostic variables included hormonal (estrogen and progesterone) and human epidermal growth factor receptor 2 (HER2) receptor refractory tumor status, high degree of axillary lymph node involvement, and short disease-free interval (DFI). All other clinical or prognostic parameters were of low or insufficient strength. Conclusion With respect to clinical outcomes, surgery consistently yielded neurologic improvements in patients presenting with a deficit with a minimal risk of worsening; however, negative prognostic factors associated with shorter survival following surgery include estrogen receptor/progesterone receptor negativity, HER2 negativity, and a short DFI.
En Bloc Resection of Solitary Functional Secreting Spinal Metastasis
Gokaslan, Ziya L. , Fisher, Charles G. , Laufer, Ilya , Weber, Michael H. , Sciubba, Daniel M. , Goodwin, C. Rory , Clarke, Michelle J.

Mayo Clinic

Global Spine Journal | July 16, 2015 | Volume: 6 | Issue: 3 | Pages: 277-283

10.1055/s-0035-1558654 | PMID 27099819 Get It

Study Design Literature review. Objective Functional secretory tumors metastatic to the spine can secrete hormones, growth factors, peptides, and/or molecules into the systemic circulation that cause distinct syndromes, clinically symptomatic effects, and/or additional morbidity and mortality. En bloc resection has a limited role in metastatic spine disease due to the current paradigm that systemic burden usually determines morbidity and mortality. Our objective is to review the literature for studies focused on en bloc resection of functionally active spinal metastasis as the primary indication. Methods A review of the PubMed literature was performed to identify studies focused on functional secreting metastatic tumors to the spinal column. We identified five cases of patients undergoing en bloc resection of spinal metastases from functional secreting tumors. Results The primary histologies of these spinal metastases were pheochromocytoma, carcinoid tumor, choriocarcinoma, and a fibroblast growth factor 23–secreting phosphaturic mesenchymal tumor. Although studies of en bloc resection for these rare tumor subtypes are confined to case reports, this surgical treatment option resulted in metabolic cures and decreased clinical symptoms postoperatively for patients diagnosed with solitary functional secretory spinal metastasis. Conclusion Although the ability to formulate comprehensive conclusions is limited, case reports demonstrate that en bloc resection may be considered as a potential surgical option for the treatment of patients diagnosed with solitary functional secretory spinal metastatic tumors. Future prospective investigations into clinical outcomes should be conducted comparing intralesional resection and en bloc resection for patients diagnosed with solitary functional secretory spinal metastasis.
Systematic Review of Surgical Treatment Outcomes of Prostate Metastases to the Spine
Fourney, Daryl R. , Fisher, Charles , Gokaslan, Ziya L. , Schmidt, M, Rhines, Laurence D. , Laufer, Ilya , Patel, Shreyaskumar , Rampersaud, Raja, Reynolds, Jeremy , Chou, Dean , Mendel, Ehud , Weber, Michael H. , Sciubba, Daniel M. , Clarke, Michelle J. , Molina, Camilo , Fehlings, Michael G. , Bettegowda, Chetan

Mayo Clinic

Global Spine Journal | May 18, 2015 | Volume: 5 | Issue: 1_suppl | Pages: s-0035-1554588-s-0035-1554588

10.1055/s-0035-1554588 Get It

Introduction Treatment of symptomatic spinal metastases through surgical decompression and reconstruction is known to improve quality of life in patients with cancer. However, most studies have been performed on patients with mixed tumor histopathology. We systematically review the literature for prognostic factors specific to the surgical treatment of prostate metastases to the spine to determine the indications and outcomes of the surgical treatment. Material and Methods A systemic review of the literature was conducted to answer the following questions: Q1. Describe the survival and functional outcomes of surgery or vertebral augmentation for prostate metastases to the spine; Q2. Determine whether overall tumor burden, Gleason score, preoperative functional markers, and favorable hormonal naivety for operative intervention; Q3. Establish whether clinical outcomes vary with the evolution of operative techniques. Expert consensus was obtained using a modified Delphi process. Results A total of 16 studies met the preset inclusion criteria. These studies were all retrospective series with a level of evidence of IV. Included studies consistently showed a large effect of hormone naivety on overall survival. In addition, studies consistently demonstrated an improvement in motor function and the ability to maintain/regain ambulation following surgery resulting in moderate strength of recommendation. All other parameters were of insufficient or low strength. Conclusion There is scant literature on the surgical treatment of prostate metastases to the spine, which represents an opportunity for future research. On the basis of the existing evidence, it appears that the surgical treatment of prostate metastases to the spine has consistently favorable results. While no consistent preoperative indicators favor nonoperative treatment, hormone naivety and high Karnofsky Performance Scores have positive effects on survival and clinical outcomes.
A Systematic Review of Clinical Outcomes and Prognostic Factors for Patients Undergoing Surgery for Spinal Metastases Secondary to Breast Cancer
Sciubba, Daniel M. , Yurter, Alp, Ju, Derek G. , Gokaslan, Ziya L. , Fisher, Charles G. , Rhines, Laurence D. , Fourney, Daryl R. , Mendel, Ehud , Laufer, Ilya , Patel, Shreyaskumar , Rampersaud, Y. Raja , Chou, Dean , Weber, Michael H. , Fehlings, Michael G. , Bettegowda, Chetan , Goodwin, C. Rory , Reynolds, Jeremy , Clarke, Michelle J.

Mayo Clinic

Global Spine Journal | May 18, 2015 | Volume: 5 | Issue: 1_suppl | Pages: s-0035-1554402-s-0035-1554402

10.1055/s-0035-1554402 Get It

Introduction Surgical treatment and cement augmentation procedures are effective palliative techniques for the treatment of symptomatic spinal metastases. However, clinical results specific to a breast cancer cohort are generally lacking. We aim to systematically review the literature for clinical outcomes following operative interventions and prognostic factors for the treatment of breast metastases to the spine. Specifically, we describe the survival and clinical outcomes of surgery and cement augmentation procedures for breast metastases to the spine and to determine prognostic variables that may help recognize which patients will perform better or worse following surgery. Methods We performed a literature review using PubMed to identify articles that reported outcomes and/or prognostic factors of the breast cancer patient population with spinal metastases treated with any surgical technique since 1990. Results A total of 19 surgical studies, 4 cement augmentation studies, and 6 nonsurgical prognostic variable studies met the preset inclusion criteria. All but three studies (two surgical and one cement augmentation) were retrospective in nature, and all studies were of level of evidence IV. Median postoperative survival for metastatic breast cancer was 21.7 months (8.2–36 months), mean rate of pain improvement was 92.9% (76–100%), mean rate of neurological improvement was 63.8% (53–100%), mean rate neurological decline was 4.1% (0–8%), and mean rate LTC was 92.6% (89–100%). Kyphoplasty studies reported a high rate of pain control in selected patients. Negative prognostic variables included: hormonal (estrogen and progesterone) and HER2 receptor refractory tumor status, high degree of axillary lymph node involvement, and short disease-free interval (DFI). All other clinical or prognostic parameters were of low or insufficient strength. Conclusion With respect to clinical outcomes, studies consistently found that surgery resulted in neurological improvement for a majority of patients, with a minimal risk of worsening, and kyphoplasty studies reported a high rate of pain control. Increased postoperative survival 2002 onwards was likely due to FDA approval of new chemotherapies. However, specific factors associated with shorter survival following surgery involve hormone and HER2 receptor status and disease-free interval.
A survey of community paramedicine course offerings and planned offerings
Raynovich, William, Wilcox, Michael R, Wingrove, Gary , Robinson-Montera, Anne, Long, Susan , Weber, Michael

Mayo Clinic

International Paramedic Practice | May 23, 2014 | Volume: 4 | Issue: 1 | Pages: 19-24

10.12968/ippr.2014.4.1.19 Get It

Introduction: This paper reports on the results of a survey that was sent to every recipient of a standardised Community Paramedic™ (CP) curriculum. The survey was sent out to 223 post-secondary educators and Government officials. Out of 223 total surveys, 68 (30.49%) responses were received. Forty-seven of the 68 responses (69.11%) answered the question: ‘When are you planning on giving a community paramedic course?’; 35 of the 47 respondents (74.46%) indicated that their institution had already conducted a CP course, was currently conducting a CP course, or are planning on conducting a CP course within the next five years; of the additional 12 programmes (25.53%), 6 (13.0%) were waiting for state approval, and the other 6 (13.0%) were unknown as to when they would be offering a course. Conclusions: At the time of the survey, many CP courses were in planning stages by programmes that had received the standardised CP curriculum, both in the US and internationally. It appears that the CP curriculum that has been disseminated internationally has been broadly accepted and will be widely utilised.
Direct Tumor Lysis by NK Cells Uses a Ras-Independent Mitogen-Activated Protein Kinase Signal Pathway
Gilvary, Danielle L., Corliss, Brian C., Sebti, Saı̈d M. , Sun, Jiazhi , Straus, David B. , Leibson, Paul J., Trapani, Joseph A. , Hamilton, Andrew D. , Weber, Michael J. , Djeu, Julie Y., Wei, Sheng

Mayo Clinic

The Journal of Immunology | April 21, 2014 | Volume: 165 | Issue: 7 | Pages: 3811-3819

10.4049/jimmunol.165.7.3811 | PMID 11034387 Get It

Abstract Destruction of tumor cells is a key function of lymphocytes, but the molecular processes driving it are unclear. Analysis of signal molecules indicated that mitogen-activated protein kinase (MAPK)/extracellular regulated kinase 2 critically controlled lytic function in human NK cells. We now have evidence to indicate that target ligation triggers a Ras-independent MAPK pathway that is required for lysis of the ligated tumor cell. Target engagement caused NK cells to rapidly activate MAPK within 5 min, and PD098059 effectively blocked both MAPK activation and tumoricidal function in NK cells. Target engagement also rapidly activated Ras, detected as active Ras-GTP bound to GST-Raf-RBD, a GST fusion protein linked to the Raf protein fragment containing the Ras-GTP binding domain. However, Ras inactivation by pharmacological disruption with the farnesyl transferase inhibitor, FTI-277, had no adverse effect on the ability of NK cells to lyse tumor cells or to express MAPK activation upon target conjugation. Notably, MAPK inactivation with PD098059, but not Ras inactivation with FTI-277, could interfere with perforin and granzyme B polarization within NK cells toward the contacted target cell. Using vaccinia delivery of N17 Ras into NK cells, we demonstrated that IL-2 activated a Ras-dependent MAPK pathway, while target ligation used a Ras-independent MAPK pathway to trigger lysis in NK cells.